Imualfa 1.6mg Injection
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Thymosin alpha (1.6mg)
Overview Imualfa 1.6mg Injection
Hepatitis B treatment with the antiviral Imualfa 1.6mg Injection involves boosting the body's defense mechanisms by enhancing protective cell activity. Administered intravenously by a medical professional only, this medication requires regular liver function monitoring. Imualfa is contraindicated in immunocompromised individuals, such as organ transplant recipients. Common side effects may include arthralgia, myasthenia, and dermatological reactions; injection site reactions such as erythema, edema, or discomfort are also possible. Persistent side effects necessitate medical consultation. Pregnant or breastfeeding individuals, and those planning pregnancy, should discuss Imualfa use with their physician.
Uses of Imualfa 1.6mg Injection
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Imualfa 1.6mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Imualfa 1.6mg Injection:
- Hypotonia (decreased muscle tone)
- Joint pain
- Skin rash
How to use Imualfa 1.6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Imualfa 1.6mg Injection works:
Imualfa 1.6mg Injection enhances the body's defense mechanisms by stimulating protective cell activity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imualfa 1.6mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Imualfa 1.6mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Imualfa 1.6mg Injection while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Imualfa 1.6mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Imualfa 1.6mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Imualfa 1.6mg Injection in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Imualfa 1.6mg Injection :
Should you forget a dose of Imualfa 1.6mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Imualfa 1.6mg Injection
| Label | Value |
|---|---|
| Type of Compound | Short chains of amino acids. |
| Potential for Dependence | None. |
| Treatment Category | Agents against infection |
| Mechanism of Action | Immunomodulatory agent: Thymosin alpha-1 |
3,018 People bought this recently